Regulatory
-
Sun Pharma Asked to Halt Clinical Research in Mumbai
The Drug Controller General of India has ordered Sun Pharmaceutical,…
Read more -
-
SC asks why govt approved 162 global clinical trials in India Apex court expresses concerns about drug trials being permitted on humans without comprehensive rules to regulate the approval process
The apex court on Monday directed the health ministry to…
Read more -
India ruling deals blow to German pharma giant
An Indian company can sell a generic version of Bayer…
Read more -
Managing constant pharmaceutical sales: Kick-starting prescriptions
Managing constant pharmaceutical sales: Kick-starting prescriptions A cursory glance at…
Read more -
Karnataka government gives a push to pharmaceutical business
BANGALORE: The Karnataka government on Wednesday announced a pharmaceutical policy…
Read more -
Criteria for fixing price of medicines : Srikant Kumar Jena
NPPA fixes or revises prices of controlled drugs / formulations…
Read more -
India Needs to Buck up its Child Health Care
India is showing positive progress in reducing child mortality with…
Read more -
Aanjaneya Lifecare Posts Robust Growth, net up by 75% in Q3, Inches Close To Acquisition
Aanjaneya Lifecare Posts Robust Growth, net up by 75% in…
Read more -
Price Control of Medicines are detrimental for India’s Healthcare Growth Story & Drives – Kewal Handa, MD, Pfizer & Wyeth India.
Price Control of Medicines are detrimental for India’s Healthcare Growth…
Read more

